Oversight Committee Hearing on FDA Regulations and Crises Management

The House Oversight Committee will hold a hearing on FDA oversight, with Director Robert Califf testifying. The committee will review ongoing investigations into the FDA's handling of issues such as infant formula crisis, food safety, drug shortages, facility inspections, cannabis regulation, tobacco and nicotine product regulation, and over-the-counter decongestants. The committee will request Califf to explain actions taken in response to these crises, inspection measures to prevent future crises, and steps to protect American consumers. The hearing will be open to the public and media.